Re: Guidelines for IHC on malignant cases

From:John McClure <>

I can't imagine of a meaningful benchmark that could be applied across the
board. It is so dependent on the H&E appearance that I would strongly
recommend against even attempting to do so.

John S. McClure MD
Pathologist, Unity Hospital
Hospital Pathology Associates

on 6/6/01 3:21 PM, Goodwin, Diana at wrote:

> Does anyone out there in the clinical world know of a standard for
> benchmarking the number of IHCs that are requested on malignant cases?  Is
> there a "national average"?  The object being to establish a "reasonable"
> average for IHC orders for cost containment purposes.
> Diana Goodwin, HT
> Trenton, NJ

<< Previous Message | Next Message >>